IP Library Granted Patent US 10,392,517
Granted Patent B2
US 10,392,517 · App. 15/108,134 · Granted Aug 27, 2019

Optical article comprising an electrically conductive layer, and production method

Inventors: Richard Liu (Singapore, SG); Hui Yu (Singapore, SG); Bastien Feret (Singapore, SG)
Assignee: ESSILOR INTERNATIONAL
C09D5/24C03C17/00C08G18/246C08G18/4018C08G18/4283C08G18/4833C08G18/73C08G83/002C08K5/42C08L101/005C09D5/00C09D5/002C09D175/04C09D175/08C09D201/005C09K3/16G02B1/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,392,517
App. No.
15/108,134
Granted
Aug 27, 2019
Kind
B2
Abstract

The present invention relates to a curable antistatic primer composition, comprising: (d) at least one polyalkylene oxide polymer; (e) at least a Lithium salt; (f) at least an amorphizer selected from at least a dendritic polymer. The present invention also relates to an optical article having at least one surface comprising an antistatic primer coating obtained by depositing on a substrate and curing said composition, and its production method.

Claims (47)

1. A curable antistatic primer composition comprising:

at least one polyalkylene oxide polymer;

at least a lithium salt; and

at least an amorphizer comprising at least a dendritic polymer wherein the composition is further defined as having a weight ratio of (dry extract of said dendritic polymer)/(dry extract of said polyalkylene oxide polymer) ranging from 0.05 to 1.5.

2. The curable composition of claim 1 , wherein the dendritic polymer is a hyperbranched polymer or a dendrimer having hydroxyl group at terminal ends thereof.

3. The curable composition of claim 2 , wherein the dendritic polymer has a degree of hydroxyl functionality from 5 to 60.

4. The curable composition of claim 1 , wherein the dendritic polymer has a number average molecular weight Mn ranging from 500 to 5000 g/mol.

5. The curable composition of claim 4 , wherein the dendritic polymer has a number average molecular weight Mn ranging from 1000 to 3000 g/mol.

6. The curable composition of claim 1 , wherein the dendritic polymer is a dendritic polyether or dendritic polyester.

7. The curable composition of claim 6 , wherein the dendritic polymer is a dendritic polyether or dendritic polyester, comprising branching units further defined as 2,2-bis(methylol)propionic acid, 2,2-bis(methylol)butanoic acid, and/or a mixture thereof.

8. The curable composition of claim 1 , wherein the polyalkylene oxide polymer has a number average molecular weight Mn ranging from 200 to 1000 g/mol.

9. The curable composition of claim 1 , wherein the polyalkylene oxide polymer is polyethylene oxide, polypropylene oxide, polybutylene oxide, or a mixture thereof.

10. The curable composition of claim 1 , further comprising a polyisocyanate which is able to form a polyurethane compound with at least the polyalkylene oxide polymer.

11. The curable composition of claim 10 , wherein the polyisocyanate is 1,6-hexamethylene diisocyanate.

12. The curable composition of claim 10 , comprising, by weight, relative to the total weight of the curable coating composition:

from 40% to 60% by weight of the polyalkylene oxide polymer;

from 5% to 15% by weight of lithium salts;

from 25% to 40% by weight of polyisocyanate; and

from 5% to 20% by weight of dendritric polymer.

13. The curable composition of claim 12 , comprising, relative to the total weight of the curable coating composition:

from 40% to 50% by weight of the polyalkylene oxide polymer.

14. The curable composition of claim 12 , further comprising:

from 10% to 25% by dry content weight of a solvent.

15. A process of preparation of a curable antistatic primer composition as defined in claim 10 , comprising:

mixing at least one polyalkylene oxide polymer with a dendritic polymer previously dried;

adding and stirring to said mixture lithium salts; and

adding a polyisocyanate.

16. The process of claim 15 , further comprising adding and mixing a catalyst and a surfactant.

17. An optical article having at least one surface on which an antistatic primer coating is obtained by depositing on a substrate and curing a curable antistatic primer composition of claim 1 .

18. The optical article of claim 17 , further defined as an ophthalmic lens.

19. A process for forming an antistatic coating onto a substrate of an optical article, said substrate having at least one face, comprising:

preparing a curable antistatic primer composition of claim 1 ;

coating the substrate with said curable antistatic primer composition; and

curing said curable antistatic primer composition.

20. A curable antistatic primer composition comprising:

at least one polyalkylene oxide polymer;

at least a lithium salt; and

at least an amorphizer comprising at least a dendritic polymer:

wherein the dendritic polymer is a hyperbranched polymer or a dendrimer having hydroxyl group at terminal ends thereof, and wherein the dendritic polymer has a degree of hydroxyl functionality from 5 to 60.

21. The curable composition of claim 20 , further comprising a polyisocyanate which is able to form a polyurethane compound with at least the polyalkylene oxide polymer.

22. The curable composition of claim 21 , comprising, by weight, relative to the total weight of the curable coating composition:

from 40% to 60% by weight of the polyalkylene oxide polymer;

from 5% to 15% by weight of lithium salts;

from 25% to 40% by weight of polyisocyanate; and

from 5% to 20% by weight of dendritric polymer.

23. The curable composition of claim 22 , further comprising:

from 10% to 25% by dry content weight of a solvent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: ESSILOR INTERNATIONAL (COMPAGNIE GÉNÉRALE D'OPTIQUE)
To: ESSILOR INTERNATIONAL
Reel/Frame 045853/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2017
From: LIU, RICHARD; YU, HUI; FERET, BASTIEN
To: ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE)
Reel/Frame 041265/0884 →
Priority Claims (1)
EP 13306861 · Dec 24, 2013 · regional
Continuity (1)
Related Publication 20160326380A1 · Nov 10, 2016